Second Annual Symposium for Nurses and Pharmacists Specializing in Oncology: Assessing and Managing Side Effects in the Era of Targeted Therapies
Dallas/Addison Marriott Quorum by the Galleria
Dallas, TX
October 24, 2009
Debra Barton, RN, PhD, AOCN, FAAN
Associate Professor of Oncology
Mayo Clinic
Rochester, MN
John G. Kuhn, PharmD, FCCP, BCOP
Professor
Pharmacotherapy Education & Research Center and Department of Medicine (Oncology)
The University of Texas Health Science Center at San Antonio
Acting Medical Research Director
South Texas Oncology/Hematology
San Antonio, TX
Jeannine Brant, PhD, APRN, AOCN
Oncology Clinical Nurse Specialist
Pain Consultant
Research Scientist
Billings Clinic Cancer Center
Billings, MT
Joseph Bubalo, PharmD, BCPS, BCOP
Assistant Professor of Medicine
Clinical Operations Manager
Oncology Clinical Pharmacist
Oregon Health & Science University
Portland, OR
Mario E. Lacouture, MD
Director, SERIES™ Clinic
Assistant Professor
Department of Dermatology
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL
Jeffrey V. Matous, MD
Physician
Rocky Mountain Cancer Center
Medical Director, Rocky Mountain Blood and Marrow Transplant Program
Associate Clinical Professor
Department of Medicine
Division of Oncology
University of Colorado Health Sciences Center
Denver, CO
Debu Tripathy, MD
Co-Leader, Women’s Cancer Program
USC/Norris Comprehensive Cancer Center
Professor of Medicine
Art and Priscilla Ulene Chair in Women’s Cancer
Division of Oncology
Keck School of Medicine
University of Southern California
Los Angeles, CA
Christine Walko, PharmD, BCOP
Assistant Professor
Department of Pharmacotherapy and Experimental Therapeutics
The University of North Carolina at Chapel Hill
Chapel Hill, NC
An educational grant for this activity was provided by: